Annika Margareta Grahn-Westin
Plus aucun poste en cours
Profil
Annika Margareta Grahn-Westin is the founder of Visionar Preclinical AB, which was founded in 2000.
She held the title of Director from 2009 to 2011.
Ms. Grahn-Westin's former job was at Pharmacia AB, where she held the title of Principal from 1976 to 1995.
Anciens postes connus de Annika Margareta Grahn-Westin
| Sociétés | Poste | Fin |
|---|---|---|
Visionar Preclinical AB
 Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials. | Fondateur | 21/11/2011 |
| Pharmacia AB | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Visionar Preclinical AB
Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials. | Commercial Services |
| Pharmacia AB | Health Technology |
